Cargando…
T198. CAN AUGMENTED SUBLINGUAL OXYTOCIN DECREASE NEGATIVE SYMPTOMS WITHIN TREATMENT RESISTANT SCHIZOPHRENIC POPULATIONS: A PILOT STUDY
BACKGROUND: The prevalence of schizophrenia in the United States ranges between 0.5% and 1%. This difficult-to-treat disorder is marked by the presentation of symptoms that are both positive (i.e. hallucinations) and negative (i.e. blunted affect), as well as disturbances in cognition and affect. Se...
Autores principales: | Marotta, Rocco, Buono, Frank, Garakani, Amir, Rowe, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234300/ http://dx.doi.org/10.1093/schbul/sbaa029.758 |
Ejemplares similares
-
T151. THE FINDINGS OF CAROTID AND CARDIAC ULTRASONOGRAPHY IN YOUNG SCHIZOPHRENIC PATIENTS
por: Tsai, Shangying, et al.
Publicado: (2020) -
T75. METABOLIC SYNDROME AND HEAR RATE VARIABILITY IN SCHIZOPHRENIC INPATIENTS
por: Yoon, Bo-Hyun, et al.
Publicado: (2020) -
T139. OXYTOCIN ENHANCES NEURAL EFFICIENCY IN INFERRING OTHERS’ SOCIAL EMOTIONS IN PEOPLE AT CLINICAL HIGH RISK FOR PSYCHOSIS
por: Schmidt, André, et al.
Publicado: (2020) -
T47. GUANFACINE AUGMENTATION OF ATTENTIONAL FUNCTIONING IN THE SCHIZOPHRENIA SPECTRUM
Publicado: (2020) -
T43. PREDNISOLONE VERSUS PLACEBO AS AUGMENTATION THERAPY IN PSYCHOTIC DISORDERS
por: Lyliana, Nasib, et al.
Publicado: (2020)